M. Wallot

Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis

Hartmut Grasemann, Enrico Michler, M. Wallot et al. · Pediatric Pulmonology · 1997 · 210 citations

Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial

Lars Klinge, Volker Straub, Ulrich Neudorf et al. · Neuromuscular Disorders · 2004 · 180 citations

Pediatric Hematology, Inherited Metabolic Disease, Clinical Epidemiology +4

A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency

Nanda M. Verhoeven, M. Wallot, Jojanneke H.J. Huck et al. · Journal of Inherited Metabolic Disease · 2005 · 63 citations

Characterization of eleven novel mutations (M45L, R119H, 544delG, G145V, H154Y, C184Y, D289V, 862+5A, 1172delC, R411X, E459K) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with severe hypophosphatasia

A. Taillandier, Laurence Zurutuza, Françoise Müller et al. · Human Mutation · 1999 · 49 citations · Full text

Genetics, Genetic Epidemiology, Pathology +17

Congenital alveolar proteinosis caused by a novel mutation of the surfactant protein B gene and misalignment of lung vessels in consanguineous kindred infants

M. Wallot, C. A. Wagenvoort, D.E. deMello et al. · European Journal of Pediatrics · 1999 · 38 citations

Developmental Anomaly, Novel Mutation, Developmental Biology +7